Tony Nguyen
Director/Board Member at Visus Therapeutics, Inc.
Profile
Tony Nguyen is currently working as a Managing Director at RTW Investments and also holds a position as a Director at Visus Therapeutics, Inc. He completed his undergraduate degree from the National University of Singapore and holds an MBA from St. John's University.
Tony Nguyen active positions
Companies | Position | Start |
---|---|---|
Visus Therapeutics, Inc.
Visus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Visus Therapeutics, Inc. is a clinical stage biopharmaceutical company that focuses on developing multi-targeted ophthalmic therapeutics for the front and back of the eye. The company is based in Seattle, WA and has subsidiaries in the United States. The company is developing novel, pupil-modulating therapeutics designed to correct the loss of near vision associated with presbyopia. In parallel, Visus is advancing its pipeline of early-stage ophthalmic drug candidates engineered to preserve and restore visual function associated with the leading causes of vision loss including cataract and presbyopia, ocular surface and corneal disease, glaucoma, and age-related macular degeneration. The company was founded by Benjamin Scot Bergo, Rhett M. Schiffman, and Benjamin Scot Bergo has been the CEO since incorporation. | Director/Board Member | - |
RTW Investments /Venture/
RTW Investments /Venture/ Investment ManagersFinance RTW Investments /Venture/ (RTW Investments) is a venture capital subsidiary of RTW Investments LP founded in 2009 by Roderick Wong. The firm is headquartered in New York. | Private Equity Investor | 2019-06-30 |
Training of Tony Nguyen
National University of Singapore | Undergraduate Degree |
St. John's University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Visus Therapeutics, Inc.
Visus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Visus Therapeutics, Inc. is a clinical stage biopharmaceutical company that focuses on developing multi-targeted ophthalmic therapeutics for the front and back of the eye. The company is based in Seattle, WA and has subsidiaries in the United States. The company is developing novel, pupil-modulating therapeutics designed to correct the loss of near vision associated with presbyopia. In parallel, Visus is advancing its pipeline of early-stage ophthalmic drug candidates engineered to preserve and restore visual function associated with the leading causes of vision loss including cataract and presbyopia, ocular surface and corneal disease, glaucoma, and age-related macular degeneration. The company was founded by Benjamin Scot Bergo, Rhett M. Schiffman, and Benjamin Scot Bergo has been the CEO since incorporation. | Health Technology |
RTW Investments /Venture/
RTW Investments /Venture/ Investment ManagersFinance RTW Investments /Venture/ (RTW Investments) is a venture capital subsidiary of RTW Investments LP founded in 2009 by Roderick Wong. The firm is headquartered in New York. | Finance |
- Stock Market
- Insiders
- Tony Nguyen